Loading clinical trials...
Loading clinical trials...
This is a Phase 1, single-center, randomized, partially double-blind, placebo- and positive controlled, 4-way crossover study to evaluate the effect of a therapeutic and a supratherapeutic dose of LC3...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
LG Chem
NCT07089888 · Tophaceous Gout
NCT07453004 · Acute Gouty Arthritis
NCT07504146 · CPPD - Calcium Pyrophosphate Deposition Disease, Gout
NCT07089875 · Gout
NCT07116746 · Gout, Gouty Arthritis, and more
PPD
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions